Replies to post #6579 on GTC Biotherapeutics (fka GTCB)

[ThomasS]

re: NVS: In light of the NVS connection to MNTA (via Sandoz), I could see a possible rationale for NVS being an eventual suitor for GTC... they might command a stranglehold, of sorts, on FoB development and production.

I didn't take the survey.

[DewDiligence]

Re: Which other company?

If I were setting up the quiz again, I’d include AZN/MedImmune among the answer choices. But I’m still curious to know which companies garnered the six survey votes for Some other company.